B3H-27928-23991
2 vaccinations
5 coded responses
25 check-ins
5 free-text entries
0 call cases
- Sex
- —
- Age at first dose
- 36-40
- ZIP prefix
- 014 / MA
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Moderna
-
2021-02-05
Survey response — day 0, dose 1MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Brain FogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Left shoulder and upper back. Injection site left sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-05
Dose 2 — Moderna
-
2021-03-05
Survey response — day 0, dose 2MedDRA: Chest discomfort, Immediate post-injection reaction — Feeling: Fair · Site: Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Tightness in chest about 30-35 minutes after shot, quickly left after about 10-15 minutesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-03-08
Survey response — days 1–6 daily, dose 2MedDRA: Injection site warmth — Feeling: Good · Site: Pain, Redness, SwellingFree text: Area of injection site is warmerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-20
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-03
-
2022-03-05
Survey response — 12 months, dose 2MedDRA: Brain fog, Fatigue, Influenza, Nausea, Pre-existing disease, Pyrexia, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had Flu first week December 2021, recieved infusion for my autoimmune 2nd week of December, tested positive for Covid on December 27, 2021. Had monoclonal antibodies on December 29th. Since then long term nausea, brain fog, fatigue, on/off fever,MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | |
| 2 | 2021-03-05 | Moderna |
Free text
Release 3 — day 0, dose 1
Systemic reaction (other): Brain Fog
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Left shoulder and upper back. Injection site left side
Release 5 — day 0, dose 2
Systemic reaction (other): Tightness in chest about 30-35 minutes after shot, quickly left after about 10-15 minutes
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Area of injection site is warmer
Release 11 — 12 months, dose 2
Symptoms: Had Flu first week December 2021, recieved infusion for my autoimmune 2nd week of December, tested positive for Covid on December 27, 2021. Had monoclonal antibodies on December 29th. Since then long term nausea, brain fog, fatigue, on/off fever,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release